Get an Insight into the Pipeline Status of Ear Infection Drugs By Company and By Stage and Also Get a Summary of the Latest News and Developments in This Area
Posted on: Wednesday, 19 September 2007, 09:02 CDT
Research and Markets (http://www.researchandmarkets.com/reports/c68871) has announced the addition of "Infections - Ear Infections Drug Pipeline Report" to their offering.
"Infections - Ear Infections Drug Pipeline Report" contains detailed information on the current drug pipeline. This report provides insight into the pipeline status of ear infections drugs by company and by stage as well as a summary of the latest news and developments in this area.
Scope of the report:
Each Therapy Area Pipeline Report provides the user with real detail on drug pipelines, by company and by stage, for each specific therapy area. The latest news, by company, also ensures that each report is fresh and up-to-date.
In addition to new developments and disease specific pipeline projects, each report also contains extensive information in tabular format on a company's full product pipeline and products by phase of development with regard to the therapy area.
Full pipeline details, by stage, are provided and include detailed product descriptions, information on partnering activity plus clinical trial intelligence. Each Therapy Area Pipeline Report also provides detail on the top 20 companies with products in the early stage of development and the top 20 companies with products in the late stage of development. Finally, each report also provides a comparison with other major indications in the disease hub based on Marketed Products vs. Pipeline Products.
Key benefits
- Understand a company's strategic position by accessing detailed independent intelligence on its product pipeline for specific therapy areas.
- Keep track of your competitors and partners by better understanding their product pipeline.
- Monitor a company's research effectiveness by determining pipeline depth and number of products in development by clinical phase for specific disease areas.
- Maintain a critical competitive advantage.
Ear Infections Pipeline Overview
--% of Projects (By Phase of Development)
--No. of Projects by Phase of Development
--Marketed Products Vs. Pipeline Products
Company Overview - Pipeline Projects
--Company Overview - Pipeline Projects
--Legend
--Top 20 companies in late stage Ear Infections Projects
--Top 20 companies in early stage Ear Infections Projects
Full Pipeline View
--Pending Approval Pipeline View
For more information, visit http://www.researchandmarkets.com/reports/c68871
Source: Life Science Analytics
Source: Business Wire
Related Articles
- USRA Honored by NASA for Design, Implementation of Critical Program/Project Management Development Program
- An Essential Study of Innovations and Pipelines for Respiratory Disorders: Discover Niche Markets, New Products and Future Developments
- Sunesis Pharmaceuticals Expands Development Leadership Team to Focus on Late-Stage Development of Voreloxin (Formerly SNS-595)
- The U.S. Coal Power Project Database Is Designed To Provide a Concise Overview of the Current Status of Domestic Projects (118 As Of 10/1/07)
- Morse LLC Announces Intent to Develop Proton Therapy Center in South Florida Using Technology From Varian Medical Systems
- Swagelok Company Names Director, Product and Market Development
- AGTC and JDRF Announce Partnership to Develop Gene Therapy for Diabetic Eye Disease
- Lucent Technologies Hosts Application Developers and Content Providers to Foster Next Generation Applications
- INSTEON Alliance Reports Over 40 New Third Party INSTEON-Enabled Products in Active Development
- Novartis Presents Positive Phase III Data on Key Compounds and Highlights Strong Late-Stage Development Pipeline
 |
 |
User Comments (0)
RSS Feeds